View in EDS PDF Full Text

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

Saved in:
Bibliographic Details
Title: Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
Authors: Davis C; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Logan N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Tyson G; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Orton R; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Harvey WT; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Perkins JS; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Mollett G; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Blacow RM; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Peacock TP; Department of Infectious Disease, Imperial College London, London, United Kingdom., Barclay WS; Department of Infectious Disease, Imperial College London, London, United Kingdom., Cherepanov P; The Francis Crick Institute, London, United Kingdom., Palmarini M; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Murcia PR; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Patel AH; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Robertson DL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Haughney J; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Thomson EC; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom., Willett BJ; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
Corporate Authors: COVID-19 Genomics UK (COG-UK) Consortium, COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators
Source: PLoS pathogens [PLoS Pathog] 2021 Dec 02; Vol. 17 (12), pp. e1010022. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1553-7374
DOI:10.1371/journal.ppat.1010022